More on abbv
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $250.33 |
|
|||
| Open | $253.93 | ||||
| 52 Wk High | $68.12 | ||||
| 52 Wk Low | $50.71 | ||||
| Day High | $259.18 | ||||
| Day Low | $252.41 | ||||
| P/E | 56.16 | ||||
| EPS | $4.61 | ||||
| Volume | 5,009,497 | ||||
- Form 4 AbbVie Inc. For: Aug 14 Filed by: Donoghoe Nicholas
- Form 8-K AbbVie Inc. For: Aug 18
- A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
- AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support
- Abbvie (ABBV) PT Raised to $300 at Wells Fargo
- Form 144 AbbVie Inc. Filed by: Donoghoe Nicholas
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
- Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices
Entities mentioned with abbv
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Dividend | View Related Stories »
- Show More...
